Stock 2929 PHARMA FOODS INTERNATIONAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharma Foods International Co., Ltd.

Equities

2929

JP3802310007

Biotechnology & Medical Research

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
844 JPY +1.81% Intraday chart for Pharma Foods International Co., Ltd. +4.46% -15.77%
Mar. 15 Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending July 31, 2024 CI
Mar. 15 Pharma Foods International Co., Ltd. Announces Dividend for the Second Quarter of the Fiscal Year Ending July 31, 2024, Payable on April 2, 2024 CI

Valuation

Fiscal Period: Juli 2018 2019 2020 2021 2022 2023
Capitalization 1 13,240 14,228 29,014 84,180 42,491 48,344
Enterprise Value (EV) 1 11,717 13,018 29,309 79,283 50,503 52,134
P/E ratio 42.3 x 28.5 x 42 x 21.9 x -114 x 15.7 x
Yield - - 0.85% 0.69% 1.37% 1.31%
Capitalization / Revenue 1.67 x 1.35 x 1.89 x 1.8 x 0.71 x 0.71 x
EV / Revenue 1.48 x 1.24 x 1.91 x 1.7 x 0.84 x 0.76 x
EV / EBITDA 30.4 x 19.4 x 30.8 x 13.5 x 31.6 x 12.5 x
EV / FCF 42.5 x -49.3 x -18.7 x 14.3 x -7.51 x 10 x
FCF Yield 2.35% -2.03% -5.33% 6.99% -13.3% 9.97%
Price to Book 3.4 x 3.3 x 5.91 x 9.95 x 6.01 x 5.02 x
Nbr of stocks (in thousands) 29,034 29,038 29,043 29,058 29,024 28,845
Reference price 2 456.0 490.0 999.0 2,897 1,464 1,676
Announcement Date 10/24/18 10/25/19 10/20/20 10/20/21 10/20/22 10/25/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juli 2018 2019 2020 2021 2022 2023
Net sales 1 7,943 10,532 15,353 46,752 60,185 68,572
EBITDA 1 385 672 952 5,855 1,600 4,156
EBIT 1 297 581 801 5,674 1,080 3,610
Operating Margin 3.74% 5.52% 5.22% 12.14% 1.79% 5.26%
Earnings before Tax (EBT) 1 313 666 847 5,765 1,423 3,543
Net income 1 313 499 690 3,841 -374 3,081
Net margin 3.94% 4.74% 4.49% 8.22% -0.62% 4.49%
EPS 2 10.78 17.19 23.76 132.1 -12.89 106.7
Free Cash Flow 1 275.5 -264.2 -1,563 5,540 -6,726 5,195
FCF margin 3.47% -2.51% -10.18% 11.85% -11.18% 7.58%
FCF Conversion (EBITDA) 71.56% - - 94.62% - 125.01%
FCF Conversion (Net income) 88.02% - - 144.23% - 168.62%
Dividend per Share - - 8.500 20.00 20.00 22.00
Announcement Date 10/24/18 10/25/19 10/20/20 10/20/21 10/20/22 10/25/23
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 295 - 8,012 3,790
Net Cash position 1 1,523 1,210 - 4,897 - -
Leverage (Debt/EBITDA) - - 0.3099 x - 5.008 x 0.9119 x
Free Cash Flow 1 276 -264 -1,563 5,540 -6,726 5,195
ROE (net income / shareholders' equity) 8.56% 12.3% 15% 57.5% -4.81% 36.9%
ROA (Net income/ Total Assets) 3.05% 4.82% 5.32% 22.8% 2.59% 6.7%
Assets 1 10,263 10,348 12,975 16,810 -14,435 46,013
Book Value Per Share 2 134.0 149.0 169.0 291.0 244.0 334.0
Cash Flow per Share 2 101.0 149.0 113.0 337.0 305.0 565.0
Capex 1 42 261 900 154 467 386
Capex / Sales 0.53% 2.48% 5.86% 0.33% 0.78% 0.56%
Announcement Date 10/24/18 10/25/19 10/20/20 10/20/21 10/20/22 10/25/23
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PHARMA FOODS INTERNATIONAL CO., LTD. Stock Pharma Foods International Co., Ltd.
-15.77% 151M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 2929 Stock
  4. Financials Pharma Foods International Co., Ltd.